By Dabin Im, Pharmaceutical Analyst Questionable Road to Approval The FDA’s recent approval of Biogen’s drug, aducanumab, for Alzheimer’s disease...
Biotech Investing
Biotech Investing
Biotech investing means betting on scientific innovation. Let’s talk about how you can turn innovation into profit.
By Dabin Im, Biotech Analyst Here is a little crash course on one of the most common health conditions in...
Alzheimer's is a degenerative brain disease that accounts for 60-80% of all dementia cases. The disease slowly moves through the...
As the world rebounds from Covid, the biotech scene is heating up for the Summer of '21. New players are...
Wall Street is a fickle lover indeed. One day you are the darling of analysts, pundits and investors, and the...
It’s been a swashbuckling tale of biotech adventure. Management and investors in Mesoblast Limited have gone to hell and back...
She’s a giant of the contemporary investment scene. Her pronouncements move markets, and she has garnered millions of stock market...
Compugen Limited ($CGEN) is a growing oncology company that exists at the nexus between information technology and biology. Can the...
Mesoblast, MESO, is an Australian based biopharmaceutical company that has been a market favorite, even though the company’s ups and...
Heading into the summer of 2020, things looked promising for Galápagos NV. In early June, the Belgian biotech and its partner,...